Skip to main content
Premium Trial:

Request an Annual Quote

SV Bio Launched to Provide POC Genomic Data Services

NEW YORK (GenomeWeb News) – Silicon Valley Biosystems, a company that provides genomic data at the point of care, has been launched.

The Foster City, Calif.-based firm was launched today with financial backing from venture capital firm Sequoia Capital to provide turnkey genomics interpretation services to clinicians "to make faster, more precise, and cost-saving decisions," according to SV Bio.

Its services examine a patient's genome at the point of care to "distill the biological data into a concise, actionable report that medical generalists and specialists can easily use as a decision support tool," the company said. Services currently available include single genes and bundled gene sets for genetically heterogeneous diseases and diseases for which the causes are known.

Also, testing of the entire genome is available for illnesses where causative genes are unknown, or when a variant has been detected but can't be determined to be causative.

The SV Bio platform fits into current clinical workflows and can accept data from any next-generation sequencing platform to determine with clinical grade sensitivity and specificity the genetic variants within a patient's DNA sequence that influences a disease or condition, the company said. It added that it takes minutes to complete the sample sequence and deliver a report to a clinician.

"The transition is occurring very rapidly nowadays from genomics as a science to genomics as a key driver of clinical medicine and decision-making at the bedside," Dietrich Stephan, founder and CEO of SV Bio, said in a statement. "As genomic sequencing costs plummet, the potential clinical impact soars. SV Bio is building the requisite bridge from the genomics bench to the bedside, assisting physicians with the accurate and actionable interpretation they need for optimizing care for each individual."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.